Edgestream Partners L.P. raised its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 119.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,472 shares of the company's stock after purchasing an additional 5,702 shares during the period. Edgestream Partners L.P.'s holdings in Henry Schein were worth $725,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its stake in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares in the last quarter. Quent Capital LLC boosted its holdings in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after acquiring an additional 323 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after acquiring an additional 143 shares in the last quarter. Finally, City State Bank acquired a new stake in Henry Schein in the fourth quarter worth about $55,000. Hedge funds and other institutional investors own 96.62% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have weighed in on the company. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target for the company. UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Mizuho began coverage on Henry Schein in a report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price for the company. Finally, Barrington Research reaffirmed an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $81.10.
Get Our Latest Analysis on Henry Schein
Henry Schein Stock Performance
NASDAQ:HSIC traded up $0.77 during trading hours on Friday, reaching $70.58. The company had a trading volume of 1,443,065 shares, compared to its average volume of 1,503,071. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The firm has a market cap of $8.76 billion, a PE ratio of 29.05, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The business's 50 day moving average price is $74.84 and its 200-day moving average price is $72.60. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.
Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the previous year, the firm posted $0.66 earnings per share. The company's revenue was up 5.8% compared to the same quarter last year. Research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.
About Henry Schein
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.